These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24809208)

  • 21. [Evaluation of the safety and efficacy of cefditoren pivoxil fine granules for pediatric use in pediatric patients with laryngopharyngitis and tonsillitis caused by Streptococcus pyogenes].
    Kawamata S; Yamada H; Sato Y; Sasagawa Y; Iwama Y; Matumoto M
    Jpn J Antibiot; 2010 Aug; 63(4):299-311. PubMed ID: 21298863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetic model of PI-88, a heparanase inhibitor.
    Hudachek SF; Eckhardt SG; Hicks B; Gustafson DL
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):743-53. PubMed ID: 19633850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simultaneous oral/intravenous population pharmacokinetic model for vinorelbine.
    Variol P; Nguyen L; Tranchand B; Puozzo C
    Eur J Clin Pharmacol; 2002 Oct; 58(7):467-76. PubMed ID: 12389069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.
    Olsson-Gisleskog P; Jacqmin P; Perez-Ruixo JJ
    Clin Pharmacokinet; 2007; 46(2):159-73. PubMed ID: 17253886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics of valnemulin in swine.
    Zhao DH; Zhang Z; Zhang CY; Liu ZC; Deng H; Yu JJ; Guo JP; Liu YH
    J Vet Pharmacol Ther; 2014 Feb; 37(1):59-65. PubMed ID: 23617793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors.
    Guo F; Letrent SP; Sharma A
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):799-809. PubMed ID: 17285315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics of ABT-767 in BRCA1 or BRCA2 mutation carriers with advanced solid tumors or in subjects with high grade serous ovarian, primary peritoneal or fallopian tube cancer.
    Mittapalli RK; Nuthalapati S; Shepherd SP; Xiong H
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):587-594. PubMed ID: 28247011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
    Zhang J; Xu JF; Liu YB; Xiao ZK; Huang JA; Si B; Sun SH; Xia QM; Wu XJ; Cao GY; Shi YG; Zhang YY
    J Infect Chemother; 2009 Oct; 15(5):293-300. PubMed ID: 19856067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous intravenous and intramiddle-ear dosing to determine cefditoren influx and efflux clearances in middle ear fluid in freely moving chinchillas.
    Zhu T; Cheung BW; Cartier LL; Giebink GS; Sawchuk RJ
    J Pharm Sci; 2003 Oct; 92(10):1947-56. PubMed ID: 14502535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of mycophenolic acid in renal transplant recipients.
    van Hest RM; van Gelder T; Vulto AG; Mathot RA
    Clin Pharmacokinet; 2005; 44(10):1083-96. PubMed ID: 16176120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo antibacterial activity of FK041, a new orally active cephalosporin.
    Tawara S; Hatano K; Wakai Y; Matsumoto S; Watanabe Y; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1999 Jul; 52(7):660-5. PubMed ID: 10513846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenicity study of the new cephalosporin antibiotic cefditoren pivoxil.
    Shindo Y; Hayashi H; Ando M; Tatebayashi T
    Arzneimittelforschung; 1996 Aug; 46(8):815-21. PubMed ID: 9125285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin.
    Jolling K; Perez Ruixo JJ; Hemeryck A; Vermeulen A; Greway T
    Eur J Pharm Sci; 2005 Apr; 24(5):465-75. PubMed ID: 15784336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in surface properties by granulation and physicochemical stability of granulated amorphous cefditoren pivoxil with additives.
    Yokoi Y; Yonemochi E; Terada K
    Int J Pharm; 2004 Aug; 280(1-2):67-75. PubMed ID: 15265548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients.
    Kappelhoff BS; Huitema AD; Crommentuyn KM; Mulder JW; Meenhorst PL; van Gorp EC; Mairuhu AT; Beijnen JH
    Br J Clin Pharmacol; 2005 Feb; 59(2):174-82. PubMed ID: 15676039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetics of cefquinome in pigs.
    Zhao DH; Zhang CY; Zhang Z; Liu ZC; Liu BT; Yu JJ; Guo JP; Deng H; Liu YH
    J Vet Pharmacol Ther; 2013 Aug; 36(4):313-9. PubMed ID: 23189984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I clinical trial of cefditoren pivoxil (ME 1207): pharmacokinetics in healthy volunteers.
    Li JT; Hou F; Lu H; Li TY; Li H
    Drugs Exp Clin Res; 1997; 23(5-6):145-50. PubMed ID: 9515223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals.
    Kappelhoff BS; Huitema AD; Yalvaç Z; Prins JM; Mulder JW; Meenhorst PL; Beijnen JH
    Clin Pharmacokinet; 2005; 44(8):849-61. PubMed ID: 16029069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of population pharmacokinetic modeling and Monte Carlo simulation to describe the pharmacodynamic profile of cefditoren in plasma and epithelial lining fluid.
    Lodise TP; Kinzig-Schippers M; Drusano GL; Loos U; Vogel F; Bulitta J; Hinder M; Sörgel F
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1945-51. PubMed ID: 17485507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.